Insider Transactions in Q1 2023 at Denali Therapeutics Inc. (DNLI)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
1,476
-0.8%
|
$42,804
$29.4 P/Share
|
|
Feb 13
2023
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
33,815
-0.75%
|
$1,014,450
$30.09 P/Share
|
|
Feb 13
2023
|
Ryan J. Watts President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
25,000
+1.09%
|
$0
$0.68 P/Share
|
|
Feb 13
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
3,497
-0.66%
|
$104,910
$30.09 P/Share
|
|
Feb 13
2023
|
Alexander O. Schuth COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Indirect |
25,000
+4.55%
|
$0
$0.68 P/Share
|
|
Feb 13
2023
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
2,119
-1.46%
|
$63,570
$30.1 P/Share
|
|
Feb 13
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,548
-1.36%
|
$76,440
$30.1 P/Share
|
|
Feb 10
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
818
-0.45%
|
$23,722
$29.8 P/Share
|
|
Feb 10
2023
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-1.11%
|
$725,000
$29.1 P/Share
|
|
Feb 10
2023
|
Ryan J. Watts President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
25,000
+1.1%
|
$0
$0.68 P/Share
|
|
Feb 09
2023
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
3,433
-0.15%
|
$102,990
$30.59 P/Share
|
|
Feb 08
2023
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
1,377
-0.94%
|
$41,310
$30.88 P/Share
|
|
Feb 08
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
1,521
-0.3%
|
$45,630
$30.89 P/Share
|
|
Feb 08
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
1,521
-0.84%
|
$45,630
$30.88 P/Share
|
|
Jan 17
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
10,000
-0.99%
|
$290,000
$29.7 P/Share
|
|
Jan 17
2023
|
Alexander O. Schuth COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+1.93%
|
$50,000
$5.28 P/Share
|
|
Jan 09
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
1,459
-0.82%
|
$40,852
$28.48 P/Share
|
|
Jan 06
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
1,451
-0.8%
|
$40,628
$28.67 P/Share
|
|
Jan 05
2023
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
4,800
-0.22%
|
$134,400
$28.44 P/Share
|
|
Jan 05
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
2,636
-0.53%
|
$73,808
$28.44 P/Share
|
|
Jan 05
2023
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
2,970
-1.99%
|
$83,160
$28.44 P/Share
|
|
Jan 05
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,636
-1.44%
|
$73,808
$28.44 P/Share
|
|
Jan 04
2023
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
5,029
-0.23%
|
$140,812
$28.73 P/Share
|
|
Jan 04
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Direct |
2,912
-1.91%
|
$81,536
$28.7 P/Share
|
|
Jan 04
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,913
-1.63%
|
$81,564
$28.69 P/Share
|
|
Jan 03
2023
|
Ryan J. Watts President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
82,240
+26.18%
|
-
|
|
Jan 03
2023
|
Alexander O. Schuth COFO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
41,120
+20.69%
|
-
|
|
Jan 03
2023
|
Carole Ho Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,120
+22.83%
|
-
|